Company Filing History:
20 out of 3,685 
1 out of 41 Years Active: 2000-2024
Title: Kevin W Gillman: Innovator in Immunomodulation and CNS Treatment
Introduction
Kevin W Gillman, based in Madison, CT, is a prominent inventor with an impressive portfolio of 21 patents. His work primarily focuses on the development of compounds that have significant potential in the fields of immunology and neurology.
Latest Patents
Among his latest innovations, Gillman has developed immunomodulators that are designed for the treatment of various diseases, including cancer and infectious diseases. Additionally, he has worked on oxazolidinones as modulators of mGluR5, which includes compounds that act as ligands, agonists, and partial agonists for the mGluR5 receptor. These advancements may contribute to addressing various disorders of the central nervous system.
Career Highlights
Gillman's career includes notable tenures at Bristol-Myers Squibb Company, where he contributed significantly to pharmaceutical innovations. His expertise in his field is reflected in the patents he holds and the impact of his work on medical research and application.
Collaborations
Throughout his career, Gillman has collaborated with several distinguished professionals, including Paul Michael Scola and David R Langley. These collaborations have enriched his research and contributed to advancing the understanding of therapeutic compounds.
Conclusion
Kevin W Gillman's contributions to science and medicine through his inventions and patents highlight his role as a key innovator. His findings not only foster advancements in treatment possibilities but also serve as a foundation for future research and development in the medical field.